YOUR SPECIALIST IN
ANTIBODY PRODUCTION

Custom Antibody and Immunoassay Development / Production

Expert in immunotechnologies since 1980, BIOTEM is a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) which provides high added value services for the development / production of custom monoclonal antibodies and immunoassays (ELISA & LFIA).

Complying with ISO 9001:2015 / ISO 13485:2016 Quality Standards, the company has been the privileged partner of almost 500 prestigious industrial and academic laboratories for their projects in fundamental research, development of improved diagnostics or promising therapeutic tools.

Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project according to the client’s specifications. As a benefit, BIOTEM is keen to propose contracts with guaranteed results.

  • 43 YEARS
    EXPERTISE
  • RESULTS
    COMMITMENT
  • 97%
    SATISFACTION RATE
  • QUALITY
    ISO 9001 & 13485

BIOTEM OFFERS
3 SERVICE AREAS OF ANTIBODY PRODUCTION

BIOTEM offers you 3 service areas with tailor-made solutions for your R&D, diagnostic and therapeutic projects.

anticorps

CUSTOM ANTIBODY
Monoclonal & Polyclonal

immunoessais

IMMUNOASSAYS
ELISA & LFIA

produits_biotem

BIOTEM PRODUCTS
Antibodies & Rapid Tests

OUR PARTNERS &
references
THEY TRUST
US
  • C. Bonnafous
    “INNATE PHARMA sought BIOTEM's expertise to develop monoclonal antibodies able to bind a key therapeutic target on FFPE samples. The challenge was to generate high affinity antibodies selective for a receptor (more...)

    C. Bonnafous

    Innate Pharma
  • G. Gilbert
    “Following the de-risking the scientific aspects of our test and whilst finalising the clinical performance of our simple, low cost, global mass-market blood test for the early detection of colorectal cancer, (more...)

    G. Gilbert

    Rhythm Biosciences
  • Y. Campion
    “In the context of one of our maturation projects, we have contacted BIOTEM for the humanization by CDR-grafting of our murine monoclonal antibody. BIOTEM’s dedicated project team has always taken in consideration (more...)

    Y. Campion

    Technology transfer office - SATT Nord
  • Kristine Fischer
    “Dianova had a specific need to develop antibodies to work in IHC with paraffin embedded sections; the team and I found that BIOTEM did a very solid job. From the choice of the immunising antigen to the design of the whole project BIOTEM contributed with good ideas to (more...)

    Kristine Fischer

    Dianova
  • C. Mary
    “We worked with BIOTEM for the in silico humanization of our antibodies by CDR grafting and were very satisfied with the quality of the reports as well as by the applied price. The amino acid modifications proposed by BIOTEM for the humanization and the optimization (more...)

    C. Mary

    Ose Immunotherapeutics
  • S. Yoon
    “In terms of antibody engineering and humanization, our team are working with BIOTEM for many years. The results were always very satisfying. (more...)

    S. Yoon

    Cyron Therapeutics